Search

everythinglearnresearchcommunity

for

Search:↓

About 19.4% of Iranian women in the study have Polycystic Ovary Syndrome, with the most common type involving irregular periods and high male hormone levels, but their heart and metabolic health is similar to women without the condition.

Lower testosterone levels in men may be linked to a higher risk of severe coronary artery disease.

Chromium salts may help with insulin sensitivity in PCOS, but more research is needed to confirm their overall effectiveness and safety.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

Melatonin may help treat PCOS symptoms in rats.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

The IRS-2 Asp/Asp genotype may increase the risk of PCOS in Chinese women, especially if they are not obese.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

Early treatment and weight management are important for teenagers with PCOS to reduce symptoms and long-term health risks.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

People with Lichen Planus, especially with mucosal involvement, are more likely to have Metabolic Syndrome, which increases their risk for heart disease and diabetes.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

Inhalation therapy may repair and protect elastin in the lungs of COPD patients.

Obesity is a major risk factor for insulin resistance in Taiwanese women with PCOS, which is also an independent risk factor for metabolic syndrome.

The document concludes that accurate diagnosis and management of PCOS are crucial due to its associated health risks.

There is no significant link between male pattern baldness and insulin resistance.

Older age, higher BMI, and family history of diabetes increase the risk of gestational diabetes in pregnant women.

Testosterone helps human pancreatic cells increase insulin release.

Female mice with disrupted 5α-reductase 1 had significant metabolic issues, including stress response problems, insulin resistance, liver fat buildup, and obesity.

Eating 500 fewer calories a day and making lifestyle changes can improve PCOS symptoms and reduce diabetes risk; more research is needed on its causes and treatments.

Mice lacking the PPARγ gene in their fat cells had almost no fat tissue, severe metabolic problems, and abnormal development of other fat-related tissues.

Irregular menstrual cycles in teenagers are linked to a higher risk of polycystic ovary syndrome and metabolic syndrome.

Women with PCOS have lower amylin levels, which are not related to their body weight.

Testosterone and finasteride raise insulin and zinc, lower chromium in male rats.

Patients with acne vulgaris have lower serum irisin levels.